Karan S. Dixit
Experienced in RASopathies

Dr. Karan S. Dixit

Hematology Oncology | Neurology | Hematology
Northwestern Medical Group
675 N St Clair St Ste 20-100, Galter Pavilion, 
Chicago, IL 
Offers Telehealth
15 Years of Experience
Experienced in RASopathies
Northwestern Medical Group
675 N St Clair St Ste 20-100, Galter Pavilion, 
Chicago, IL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Karan Dixit is a Hematologist Oncology specialist and a Neurologist in Chicago, Illinois. Dr. Dixit has been practicing medicine for over 15 years and is rated as an Experienced provider by MediFind in the treatment of RASopathies. His top areas of expertise are Glioma, Astrocytoma, Brain Tumor, Glioblastoma, and Gastrostomy.

His clinical research consists of co-authoring 46 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
Louisiana State University School Of Medicine, 2011.0
Residency
University of Illinois College of Medicine at Chicago
Specialties
Hematology Oncology
Neurology
Hematology
Licenses
Internal Medicine in IL
Board Certifications
American Board Of Psychiatry And Neurology - Neurology (Certified)
Fellowships
McGaw Medical Center of Northwestern University
Hospital Affiliations
Northwestern Memorial Hospital
Northwestern Lake Forest Hospital
Northwestern Medicine Mchenry
Northwestern Medicine Central Dupage Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Celtic
  • HMO
  • INSURANCE PLAN
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Alliance
  • EPO
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
SelectHealth
  • HMO
  • POS
Spectrum Priority Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 13 Less Insurance Carriers -

Locations

675 N St Clair St Ste 20-100, Galter Pavilion, Chicago, IL 60611
Call: 312-695-4360

Additional Areas of Focus

Dr. Dixit has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Neurofibromatosis Type 1 (NF1)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Randomized Phase II/III Open-Label Study of Ipilimumab and Nivolumab Versus Temozolomide in Patients With Newly Diagnosed MGMT (Tumor O-6-Methylguanine DNA Methyltransferase) Unmethylated Glioblastoma
A Randomized Phase II/III Open-Label Study of Ipilimumab and Nivolumab Versus Temozolomide in Patients With Newly Diagnosed MGMT (Tumor O-6-Methylguanine DNA Methyltransferase) Unmethylated Glioblastoma
Enrollment Status: Active_not_recruiting
Publish Date: October 02, 2025
Intervention Type: Other, Biological, Procedure, Drug, Radiation, Device
Study Drugs: Ipilimumab, Nivolumab, Temozolomide
Study Phase: Phase 2/Phase 3
Phase 1 / 2 Trial of Blood-brain Barrier Opening With an Implantable Ultrasound Device SonoCloud-9 and Treatment With Albumin-bound Paclitaxel and Carboplatin in Patients With Recurrent Glioblastoma
Phase 1 / 2 Trial of Blood-brain Barrier Opening With an Implantable Ultrasound Device SonoCloud-9 and Treatment With Albumin-bound Paclitaxel and Carboplatin in Patients With Recurrent Glioblastoma
Enrollment Status: Active_not_recruiting
Publish Date: July 31, 2025
Intervention Type: Drug, Device
Study Drug: Chemotherapy, Albumin-Bound Paclitaxel
Study Phase: Phase 1/Phase 2
A Phase III Randomized, Double-Blind Placebo Controlled Study of Armodafinil (Nuvigil®) To Reduce Cancer-Related Fatigue in Patients With High Grade Glioma
A Phase III Randomized, Double-Blind Placebo Controlled Study of Armodafinil (Nuvigil®) To Reduce Cancer-Related Fatigue in Patients With High Grade Glioma
Enrollment Status: Completed
Publish Date: January 27, 2025
Intervention Type: Other, Drug
Study Phase: Phase 3
A Phase 0 First-In-Human Study Using NU-0129: A Spherical Nucleic Acid (SNA) Gold Nanoparticle Targeting BCL2L12 in Recurrent Glioblastoma Multiforme or Gliosarcoma Patients
A Phase 0 First-In-Human Study Using NU-0129: A Spherical Nucleic Acid (SNA) Gold Nanoparticle Targeting BCL2L12 in Recurrent Glioblastoma Multiforme or Gliosarcoma Patients
Enrollment Status: Completed
Publish Date: August 26, 2022
Intervention Type: Other, Drug
Study Phase: Early Phase 1
View 3 Less Clinical Trials

46 Total Publications

Surgical Treatment of Brain Tumor-Related Epilepsy: Current and Emerging Strategies.
Surgical Treatment of Brain Tumor-Related Epilepsy: Current and Emerging Strategies.
Journal: Cancers
Published: October 06, 2025
View All 46 Publications
Similar Doctors
Distinguished in RASopathies
Dr. James Tonsgard
Pediatrics | Neurology
Distinguished in RASopathies
Dr. James Tonsgard
Pediatrics | Neurology

The University Of Chicago

5841 S Maryland Ave, 
Chicago, IL 
 (7.4 miles away)
773-702-1000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

James Tonsgard is a Pediatrics specialist and a Neurologist in Chicago, Illinois. Dr. Tonsgard is rated as an Elite provider by MediFind in the treatment of RASopathies. His top areas of expertise are Neurofibromatosis, Neurofibromatosis Type 1 (NF1), Neurofibromatosis Type 2 (NF2), and RASopathies.

Advanced in RASopathies
Dr. Arkadiy Konyukhov
Neurology
Advanced in RASopathies
Dr. Arkadiy Konyukhov
Neurology

Edward Health Ventures

1200 S York St Ste 3280, 
Elmhurst, IL 
 (16.7 miles away)
331-221-9095
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Arkadiy Konyukhov is a Neurologist in Elmhurst, Illinois. Dr. Konyukhov is rated as an Advanced provider by MediFind in the treatment of RASopathies. His top areas of expertise are Epilepsy, Memory Loss, Transient Ischemic Attack (TIA), and Legius Syndrome.

Advanced in RASopathies
Dr. Stefania Maraka
Neurology
Advanced in RASopathies
Dr. Stefania Maraka
Neurology

The Board Of Trustees Of The University Of Illinois

912 S Wood St, Uic Neurology, 
Chicago, IL 
 (3.5 miles away)
312-996-6496
Languages Spoken:
English
See accepted insurances

Stefania Maraka is a Neurologist in Chicago, Illinois. Dr. Maraka is rated as an Advanced provider by MediFind in the treatment of RASopathies. Her top areas of expertise are Neurofibromatosis, Brain Tumor, Glioblastoma, and Astrocytoma.

VIEW MORE RASOPATHIES DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Dixit's expertise for a condition
ConditionClose
    • Distinguished
    • Astrocytoma
      Dr. Dixit is
      Distinguished
      . Learn about Astrocytoma.
      See more Astrocytoma experts
    • Atypical Teratoid Rhabdoid Tumor (ATRT)
      Dr. Dixit is
      Distinguished
      . Learn about Atypical Teratoid Rhabdoid Tumor (ATRT).
      See more Atypical Teratoid Rhabdoid Tumor (ATRT) experts
    • Brain Tumor
      Dr. Dixit is
      Distinguished
      . Learn about Brain Tumor.
      See more Brain Tumor experts
    • Embryonal Tumor with Multilayered Rosettes
      Dr. Dixit is
      Distinguished
      . Learn about Embryonal Tumor with Multilayered Rosettes.
      See more Embryonal Tumor with Multilayered Rosettes experts
    • Ependymoma
      Dr. Dixit is
      Distinguished
      . Learn about Ependymoma.
      See more Ependymoma experts
    • Glioblastoma
      Dr. Dixit is
      Distinguished
      . Learn about Glioblastoma.
      See more Glioblastoma experts
    View All 15 Distinguished Conditions
    • Advanced
    • Acute Myeloblastic Leukemia without Maturation
      Dr. Dixit is
      Advanced
      . Learn about Acute Myeloblastic Leukemia without Maturation.
      See more Acute Myeloblastic Leukemia without Maturation experts
    • Acute Myeloid Leukemia (AML)
      Dr. Dixit is
      Advanced
      . Learn about Acute Myeloid Leukemia (AML).
      See more Acute Myeloid Leukemia (AML) experts
    • Adult Soft Tissue Sarcoma
      Dr. Dixit is
      Advanced
      . Learn about Adult Soft Tissue Sarcoma.
      See more Adult Soft Tissue Sarcoma experts
    • Alveolar Soft Part Sarcoma
      Dr. Dixit is
      Advanced
      . Learn about Alveolar Soft Part Sarcoma.
      See more Alveolar Soft Part Sarcoma experts
    • Bone Tumor
      Dr. Dixit is
      Advanced
      . Learn about Bone Tumor.
      See more Bone Tumor experts
    • Gliomatosis Cerebri
      Dr. Dixit is
      Advanced
      . Learn about Gliomatosis Cerebri.
      See more Gliomatosis Cerebri experts
    View All 13 Advanced Conditions
    • Experienced
    • Absence Seizure
      Dr. Dixit is
      Experienced
      . Learn about Absence Seizure.
      See more Absence Seizure experts
    • Acoustic Neuroma
      Dr. Dixit is
      Experienced
      . Learn about Acoustic Neuroma.
      See more Acoustic Neuroma experts
    • Acute Flaccid Myelitis (AFM)
      Dr. Dixit is
      Experienced
      . Learn about Acute Flaccid Myelitis (AFM).
      See more Acute Flaccid Myelitis (AFM) experts
    • ALK-Positive Non-Small Cell Lung Cancer
      Dr. Dixit is
      Experienced
      . Learn about ALK-Positive Non-Small Cell Lung Cancer.
      See more ALK-Positive Non-Small Cell Lung Cancer experts
    • Anti-NMDA Receptor Encephalitis
      Dr. Dixit is
      Experienced
      . Learn about Anti-NMDA Receptor Encephalitis.
      See more Anti-NMDA Receptor Encephalitis experts
    • Apoplexy
      Dr. Dixit is
      Experienced
      . Learn about Apoplexy.
      See more Apoplexy experts
    View All 111 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

        Close
        0 / 1000

        Please provide us with the below insurance information:

                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.